Skip to main content
SpringerLink
Log in

Disruptive Psychopharmacology

  • Book
  • © 2022

Overview

Editors:
  1. Frederick S. Barrett

    1. Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Katrin H. Preller

    1. Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich, University of Zurich, Zürich, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Summarizes the state of the science of safety and efficacy of psychedelic therapies
  • Reviews theoretical models and approaches to psychedelic therapies
  • Treats both theoretical and practical aspects of psychedelic therapies

Part of the book series: Current Topics in Behavioral Neurosciences (CTBN, volume 56)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Front Matter

    Pages i-viii
    Download chapter PDF

  2. Models and Approaches

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Dosing Psychedelics and MDMA

      • Matthias E. Liechti, Friederike Holze
      Pages 3-21

    3. Psychedelic Group Therapy

      • Peter Gasser
      Pages 23-34

    4. Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature

      • Tasha L. Golden, Susan Magsamen, Clara C. Sandu, Shuyang Lin, Grace Marie Roebuck, Kathy M. Shi et al.
      Pages 35-70

    5. Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults

      • Alicia Danforth
      Pages 71-92

    6. Foundations for Training Psychedelic Therapists

      • Janis Phelps, James Henry
      Pages 93-109

  3. Disruptive Psychopharmacology for Mood Disorders

    1. Front Matter

      Pages 111-111
      Download chapter PDF

    2. Ayahuasca for the Treatment of Depression

      • Fernanda Palhano-Fontes, Bruno Lobão Soares, Nicole Leite Galvão-Coelho, Emerson Arcoverde, Draulio B. Araujo
      Pages 113-124

    3. Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach

      • Gabrielle Agin-Liebes, Alan K. Davis
      Pages 125-140

    4. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics

      • Marina Kojic, Johan Saelens, Bashkim Kadriu, Carlos A. Zarate Jr, Christoph Kraus
      Pages 141-167

    5. The Potential of Psychedelics for End of Life and Palliative Care

      • David B. Yaden, Sandeep M. Nayak, Natalie Gukasyan, Brian T. Anderson, Roland R. Griffiths
      Pages 169-184

  4. Disruptive Psychopharmacology for Other Disorders

    1. Front Matter

      Pages 185-185
      Download chapter PDF

    2. Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action

      • Nathalie M. Rieser, Marcus Herdener, Katrin H. Preller
      Pages 187-211

    3. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation

      • Matthew W. Johnson
      Pages 213-227

    4. Psychedelics and Anti-inflammatory Activity in Animal Models

      • Thomas W. Flanagan, Charles D. Nichols
      Pages 229-245

    5. Psilocybin for the Treatment of Obsessive-Compulsive Disorders

      • Katja Ehrmann, John J. B. Allen, Francisco A. Moreno
      Pages 247-259

    6. Psychedelics in the Treatment of Headache and Chronic Pain Disorders

      • Emmanuelle A. D. Schindler
      Pages 261-285

    7. Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms

      • Albert Garcia-Romeu, Sean Darcy, Hillary Jackson, Toni White, Paul Rosenberg
      Pages 287-317

    8. Psilocybin for Trauma-Related Disorders

      • Amanda J. Khan, Ellen Bradley, Aoife O’Donovan, Joshua Woolley
      Pages 319-332
Back to top

Keywords

About this book

Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.

Editors and Affiliations

  • Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, USA

    Frederick S. Barrett

  • Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich, University of Zurich, Zürich, Switzerland

    Katrin H. Preller

Bibliographic Information

  • Book Title: Disruptive Psychopharmacology

  • Editors: Frederick S. Barrett, Katrin H. Preller

  • Series Title: Current Topics in Behavioral Neurosciences

  • DOI: https://doi.org/10.1007/978-3-031-12184-5

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022

  • Hardcover ISBN: 978-3-031-12183-8Published: 27 August 2022

  • Softcover ISBN: 978-3-031-12186-9Published: 28 August 2023

  • eBook ISBN: 978-3-031-12184-5Published: 25 August 2022

  • Series ISSN: 1866-3370

  • Series E-ISSN: 1866-3389

  • Edition Number: 1

  • Number of Pages: VIII, 332

  • Number of Illustrations: 70 b/w illustrations, 30 illustrations in colour

  • Topics: Neurosciences, Psychiatry, Neurology

Publish with us

Policies and ethics

Back to top

Search

Navigation